Skip to main content
. Author manuscript; available in PMC: 2020 Oct 15.
Published in final edited form as: J Immunol. 2020 Mar 13;204(8):2076–2087. doi: 10.4049/jimmunol.1900769

Figure 6. Targeting HuR by DHTS ameliorates chronic EAE.

Figure 6.

EAE disease course in WT mice that were injected i.p. with either DHTS or PBS every other day starting from day 5 (A) or 15 (B) after disease induction with MOG in complete Freund’s adjuvant (CFA. (C) Representative histopathology of spinal cords of EAE mice treated with PBS or DHTS were stained by H&E, Luxol fast blue and anti-CD11b staining. (D) Representative CD4+IL-17 and CD4+ IFN-γ producing cells in the splenocytes of EAE mice treated with PBS or DHTS as described in panel B at the end of experiment (day 30) were shown. (E) Summary of the flow cytometry data of CD4+IL-17 and CD4+ IFN-γ-producing cells in the spleen of EAE mice treated with PBS or DHTS at the end of experiment (day 30). (F) Naïve CD4+ T cells were cultured under Th17 cell polarization condition with or without different dosage of DHTS (1 to 2μM/ml) for 72 hours. Representative flow cytometry data was shown. (G) Summary of three independent experiments were shown for frequency of CD4+IL-17+ T cells measured by flow cytometry assay (mean ± SEM). *, p<0.05; **, p<0.01; *** p<0.001. Data in panel A are summary of two experiments (N=10 mice/per group). Data in panel B represent one of two independent experiments (N=7 mice/per group).